Table 1 Clinical patient characteristics
Patient no. | Age | Sex | Tumor type | Other therapy with initial capecitabine | Imaging tracer |
|---|---|---|---|---|---|
1 | 47 | F | Breast | Lapatinib | 18F-FLT |
2 | 65 | F | Breast | None | |
3 | 62 | F | Esophageal | Radiation | |
4 | 62 | F | Colorectal | Bevacizumab, Oxaliplatin | |
5 | 56 | F | Colorectal | Oxaliplatin | |
6 | 63 | F | Breast | None | 18F-FMAU |
7 | 52 | F | Breast | Lapatinib | |
8 | 46 | F | Breast | Lapatinib | |
9 | 73 | F | Breast | None | |
10 | 63 | F | Breast | None | |
11 | 64 | F | Breast | None | 18F-FAU |
12 | 62 | F | Colorectal | Oxaliplatin, Bevacizumab | |
13 | 53 | F | Gastric | None | |
14 | 49 | M | Colorectal | Radiation | |
15 | 37 | M | Esophageal | Oxaliplatin, Trastuzumab |